CEO, President, Cryoport
WHY: Leads cold-chain logistics service provider to the biopharmaceutical industry, backed by $25M cash infusion in 2018 from Petrichor Healthcare Capital Management. $625M market cap.
RECENT: In May paid $20.5M to buy Cryogene, which handles secure storage of biological specimens, materials, and samples.
NOTABLE: Thirty years of experience working in a range of industries, including information services, telecommunications, manufacturing and distribution.
